Fetal nigral transplantation as a therapy for Parkinson's disease (Q41367101)

30 September 2017

1 reference

title

Fetal nigral transplantation as a therapy for Parkinson's disease (English)

1 reference

30 September 2017

1 reference

Kordower JH

1 reference

30 September 2017

Olanow CW

1 reference

30 September 2017

Freeman TB

series ordinal

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

30 September 2017

published in

Trends in Neurosciences

1 reference

30 September 2017

1 reference

30 September 2017

1 reference

30 September 2017

page(s)

102-109

1 reference

Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine System

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Survival, growth and function of dopaminergic neurons grafted to the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Survival and growth of fetal catecholamine neurons transplanted into primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Effect of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Functional activity of substantia nigra grafts reinnervating the striatum: neurotransmitter metabolism and [14C]2-deoxy-D-glucose autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Fetal neural graft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Development of dopaminergic neurons in the human substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Cryopreservation, culture, and transplantation of human fetal mesencephalic tissue into monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Cryopreservation and storage of embryonic rat mesencephalic dopamine neurons for one year: comparison to fresh tissue in culture and neural grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Tyrosine hydroxylase immunoreactivity and monoamine and metabolite levels in cryopreserved human fetal ventral mesencephalon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Dopamine and cholecystokinin immunoreactive neurons in mesencephalic grafts reinnervating the neostriatum: evidence for selective growth regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

A comparison of the behavioural effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Neurogenesis in the rat neostriatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Microstimulation of the primate neostriatum. II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

An Autoradiographic Analysis of the Efferent Connections from Premotor and Adjacent Prefrontal Regions (Areas 6 and 9) in <i>Macaca fascicularis</i>; pp. 185–209

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Organization of the ascending striatal afferents in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Role of primate basal ganglia and frontal cortex in the internal generation of movements. I. Preparatory activity in the anterior striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Functional reactivation of the deafferented neostriatum by nigral transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Cyclosporin A enhances the survivability of mouse cerebral cortex grafted into the third ventricle of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Fetal homotransplants in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Core assessment program for intracerebral transplantations (CAPIT)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

The role of positron emission tomography in the assessment of human neurotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Fetal nondopaminergic neural implants in parkinsonian primates. Histochemical and behavioral studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Putative chromaffin cell survival and enhanced host-derived TH-Fiber innervation following a functional adrenal medulla autograft for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Transplantation of human sympathetic neurons and adrenal chromaffin cells into parkinsonian monkeys: no reversal of clinical symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

PET studies of parkinsonian patients treated with autologous adrenal implants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Neural-targeted gene therapy for rodent and primate hemiparkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2896%2980038-5

7 January 2021

10.1016/S0166-2236(96)80038-5

Identifiers

DOI

1 reference

30 September 2017

1 reference